Shilpa Medicare Limited Announces Special Window for Share Transfer and Dematerialization
Shilpa Medicare Limited is offering a special window for transferring and dematerializing physical shares sold/purchased before April 1, 2019. The window is open for one year from February 5, 2026, to February 4, 2027. Transferred shares will be in demat mode with a one-year lock-in.
This is a routine regulatory compliance announcement concerning the handling of physical shares and does not directly impact the company's operations, financial performance, or strategic direction.
The announcement is a regulatory compliance update regarding a special window for share transfer and dematerialization, which is a procedural matter and does not inherently carry a positive or negative financial implication for the company.
Shilpa Medicare Limited has announced a special window for the transfer and dematerialization of physical shares. This initiative is in compliance with SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026. The special window is available for a period of one year, from February 05, 2026, to February 04, 2027. It is specifically for physical securities that were sold or purchased before April 01, 2019, and were subsequently rejected or returned due to documentation or process deficiencies.
Requests submitted during this period must include original share certificates, executed transfer deeds, and other required supporting documents. Securities transferred under this window will be mandatorily credited to the transferee in demat mode and will be under a one-year lock-in period from the date of registration of transfer. During this lock-in period, the securities cannot be transferred, lien-marked, or pledged. Shareholders are encouraged to utilize this SEBI-provided opportunity.
The notice of this special window is also available on the company's website, www.vbshilpa.com. Eligible shareholders can submit their requests along with the necessary documents to the Company's Registrar and Share Transfer Agent, M/s. Kfin Technologies Limited, located at Selenium Tower B, Plot 31-32, Gachibowli, Financial District, Nanakramguda, Hyderabad - 500032.
What to do with a filing like this
Shilpa Medicare Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shilpa Medicare Limited. Read the original for the full detail.